Literature DB >> 29364478

Silencing of hsa_circ_0007534 suppresses proliferation and induces apoptosis in colorectal cancer cells.

R Zhang1, J Xu, J Zhao, X Wang.   

Abstract

OBJECTIVE: Although some circRNAs have been found to regulate the progression of colorectal cancer (CRC). However, their functions have not been completely clarified. In the present study, a novel circRNA hsa_circ_0007534 was investigated in CRC tumor tissues and cell lines. PATIENTS AND METHODS: The expression profile of circRNAs in CRC tumor tissues was performed by human circRNA microarray. The CCK-8 and apoptosis assay were measured in CRC cell lines after transfected with si-circRNA and si-NC.
RESULTS: We analyzed a cohort of 33 patients with CRC and demonstrated that the expression of hsa_circ_0007534 was significantly up-regulated in CRC tumor tissues as compared to adjacent non-tumorous tissues. Moreover, hsa_circ_0007534 expression was correlated with tumor stage and lymph node metastasis. Furthermore, the silence of hsa_circ_0007534 by siRNA significantly inhibited proliferation and induced apoptosis of CRC cells.
CONCLUSIONS: Hsa_circ_0007534 plays a crucial role in the initiation and progression of CRC and may be a potential therapeutic target of CRC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29364478     DOI: 10.26355/eurrev_201801_14108

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  28 in total

1.  Hsa_circ_0000467 promotes cancer progression and serves as a diagnostic and prognostic biomarker for gastric cancer.

Authors:  Jun Lu; Peng-Yang Zhang; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Chang-Ming Huang; Ping Li; Chao-Hui Zheng
Journal:  J Clin Lab Anal       Date:  2018-11-21       Impact factor: 2.352

Review 2.  Roles of circular RNA in breast cancer: present and future.

Authors:  Zehuan Li; Zhanghan Chen; Guohua Hu; Ying Jiang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

3.  Hsa_circ_101555 functions as a competing endogenous RNA of miR-597-5p to promote colorectal cancer progression.

Authors:  Zhenlong Chen; Rui Ren; Daiwei Wan; Yilin Wang; Xiaofeng Xue; Min Jiang; Jiaqing Shen; Ye Han; Fei Liu; Jianming Shi; Yuting Kuang; Wei Li; Qiaoming Zhi
Journal:  Oncogene       Date:  2019-07-12       Impact factor: 9.867

4.  Circ_0007534 Silencing Inhibits the Proliferation, Migration and Invasion and Induces the Apoptosis of Glioma Cells Partly Through Down-Regulating PROX1 Via Elevating miR-22-3p Level.

Authors:  Yong Zheng; Yan Wang; Rongkang Mai; Liang Liu; Zifeng Zhu; Yiyao Cao
Journal:  Cell Mol Neurobiol       Date:  2021-09-18       Impact factor: 4.231

5.  The Use of circRNAs as Biomarkers of Cancer.

Authors:  Carla Solé; Gartze Mentxaka; Charles H Lawrie
Journal:  Methods Mol Biol       Date:  2021

6.  Circ_0132817 facilitates cell proliferation, migration, invasion and glycolysis by regulating the miR-432-5p/NOL4L axis in neuroblastoma.

Authors:  Yafei Fang; Yuqian Yao; Kangwei Mao; Yanyan Zhong; Yan Xu
Journal:  Exp Brain Res       Date:  2021-04-10       Impact factor: 1.972

7.  Upregulation of circular and linear METTL3 and USP3 in colorectal cancer.

Authors:  Bilal Alkhizzi; Mohammad Imran Khan; Ayat Al-Ghafari; Hani Choudhry
Journal:  Oncol Lett       Date:  2021-07-19       Impact factor: 3.111

Review 8.  Circular RNAs as novel potential biomarkers for pancreatic cancer.

Authors:  Shanshan Liu; Qiuyue Li; Yan Ma; Christopher Corpe; Jin Wang
Journal:  J Cancer       Date:  2021-06-01       Impact factor: 4.207

Review 9.  Roles of circular RNAs in colorectal cancer.

Authors:  Mingying Zhang; Shubin Wang
Journal:  Oncol Lett       Date:  2021-06-10       Impact factor: 2.967

10.  Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622.

Authors:  Jingpeng Wang; Shuyuan Li; Gaofeng Zhang; Huihua Han
Journal:  J Biol Res (Thessalon)       Date:  2021-06-28       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.